Mitsubishi Chemical Group Corporation

03/27/2023 | Press release | Distributed by Public on 03/27/2023 01:08

Approval of “GOBIK Aqueous Suspension Syringes”, Pertussis, Diphtheria, Tetanus, Inactivated Polio and Hib Combined VaccineNEW

Mitsubishi Tanabe Pharma Corporation, a member of the Mitsubishi Chemical Group, has announced the following press release.

■Mitsubishi Tanabe Pharma　Press Release
Approval of "GOBIK Aqueous Suspension Syringes", Pertussis, Diphtheria, Tetanus, Inactivated Polio and Hib Combined Vaccine
https://www.mt-pharma.co.jp/e/news/assets/pdf/e_MTPC230327_2.pdf